SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing.
|
23881933 |
2013 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression.
|
21438761 |
2011 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
To identify the molecular basis of ALS4, we tested 19 genes within the ALS4 interval and detected missense mutations (T3I, L389S, and R2136H) in the Senataxin gene (SETX).
|
15106121 |
2004 |
Amyotrophic Lateral Sclerosis
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Ataxias, Hereditary
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Charcot-Marie-Tooth Disease
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the Senataxin gene (SETX) are associated with autosomal recessive ataxia-ocular apraxia 2 (AOA2) and autosomal dominant juvenile ALS (ALS4).
|
16717225 |
2006 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The patient carrying the p.K992R SETX polymorphism had a phenotype similar to that of the diagnosed AOA2 patients, while the other three undiagnosed subjects had a very late onset and a few distinguishing clinical features.
|
23941260 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
|
14770181 |
2004 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Senataxin (SETX) is an RNA/DNA helicase implicated in transcription termination and the DNA damage response and is mutated in two distinct neurological disorders: AOA2 (ataxia oculomotor apraxia 2) and ALS4 (amyotrophic lateral sclerosis 4).
|
24105744 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
In this paper, we document two cases of a new SETX mutation (820:A>G) combined with an established recessive SETX mutation (5927:T>G) causing ataxia with oculomotor apraxia type 2 (AOA2).
|
23566282 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Spinocerebellar ataxia autosomal recessive 1 (SCAR1/AOA2) is clinically characterized by an early-onset progressive cerebellar ataxia with axonal neuropathy, ocular motor apraxia, and elevation of serum alpha-fetoprotein level.
|
23786967 |
2013 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome.
|
17096168 |
2007 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A severe recessive cerebellar ataxia, Ataxia-Oculomotor Apraxia 2 (AOA2) and a juvenile onset form of dominant amyotrophic lateral sclerosis (ALS4) result from mutations of the Senataxin (SETX) gene.
|
16644229 |
2006 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage.
|
24105744 |
2013 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
We further found that L389S senataxin interacts with other proteins containing regions of conserved homology with the BCYRN1 reverse complement-encoded peptide, suggesting that such aberrant protein interactions may contribute to L389S ALS4 disease pathogenesis.
|
24244371 |
2013 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
|
14770181 |
2004 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
To identify the molecular basis of ALS4, we tested 19 genes within the ALS4 interval and detected missense mutations (T3I, L389S, and R2136H) in the Senataxin gene (SETX).
|
15106121 |
2004 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Senataxin mutations and amyotrophic lateral sclerosis.
|
21190393 |
2011 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
|
14770181 |
2004 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
Complex genetics of amyotrophic lateral sclerosis.
|
15478096 |
2004 |
Amyotrophic Lateral Sclerosis 4, Juvenile
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
To identify the molecular basis of ALS4, we tested 19 genes within the ALS4 interval and detected missense mutations (T3I, L389S, and R2136H) in the Senataxin gene (SETX).
|
15106121 |
2004 |
Amyotrophic Lateral Sclerosis
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|